AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok

D. C. Des Jarlais, K. Choopanya, S. Vanichseni, K. Plangsringarm, W. Sonchai, M. Carballo, P. Friedmann, S. R. Friedman

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus (HIV) seroconversion was studied in a group of 173 injection drug users in Bangkok, Thailand, who had been previously tested for HIV and were interviewed and retested in the fall of 1989. Ten percent of the group had seroconverted. Two factors protected against HIV seroconversion: having stopped sharing injection equipment in response to the acquired immunodeficiency syndrome (AIDS) and having a regular sexual partner. The association between self-reported deliberate risk reduction and reduced HIV seroconversion among persons continuing to inject illicit drugs indicates that injection drug users can change their behavior in response to AIDS and will accurately report on the behavior change, and that the changes can protect against HIV infection.

Original languageEnglish (US)
Pages (from-to)452-455
Number of pages4
JournalAmerican journal of public health
Volume84
Issue number3
DOIs
StatePublished - Jan 1 1994

    Fingerprint

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Des Jarlais, D. C., Choopanya, K., Vanichseni, S., Plangsringarm, K., Sonchai, W., Carballo, M., Friedmann, P., & Friedman, S. R. (1994). AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. American journal of public health, 84(3), 452-455. https://doi.org/10.2105/AJPH.84.3.452